The Patent Finder

Gene Therapies for Lysosomal Disorders (2019)

Prevail Therapeutics, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application PCT/US2018/054225, filed Oct 3, 2018. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 10,837,028Gene Therapies for Lysosomal Disorders
In force
 · High confidence
UsedRemaining
Prevail Therapeutics, Inc.In forceHigh confidence
US 11,060,113Gene Therapies for Lysosomal Disorders
In force
 · High confidence
Prevail Therapeutics, Inc.In forceHigh confidence
US 12,571,002Gene Therapies for Lysosomal Disorders
In force
 · High confidence
Prevail Therapeutics, Inc.In forceHigh confidence
US 11,802,294Gene Therapies for Lysosomal Disorders
In force
 · High confidence
Prevail Therapeutics, Inc.In forceHigh confidence
Application 19/465,370Gene Therapies for Lysosomal Disorders
Pending
Not granted
Prevail Therapeutics, Inc.PendingNot granted
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Prevail Therapeutics, Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited